Page last updated: 2024-11-02

oxidopamine and Hemorrhagic Shock

oxidopamine has been researched along with Hemorrhagic Shock in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research Excerpts

ExcerptRelevanceReference
"The early stress responses to hemorrhagic shock, trauma and endotoxicosis are associated with an early proinflammatory response characterized by increased gene expression of proinflammatory cytokines, PMN influx and accumulation in the lung and apoptosis."1.31Noradrenergic inhibition of TNF upregulation in hemorrhagic shock. ( Molina, PE, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molina, PE1

Other Studies

1 other study available for oxidopamine and Hemorrhagic Shock

ArticleYear
Noradrenergic inhibition of TNF upregulation in hemorrhagic shock.
    Neuroimmunomodulation, 2001, Volume: 9, Issue:3

    Topics: Animals; Apoptosis; beta-Endorphin; Catecholamines; Corticosterone; Hypotension; Lung; Male; Neuroim

2001